Literature DB >> 16092091

In vitro models of multiple system atrophy.

Nadia Stefanova1, Markus Reindl, Werner Poewe, Gregor K Wenning.   

Abstract

alpha-Synuclein represents the major constituent of oligodendroglial cytoplasmic inclusions, the hallmark lesion of multiple system atrophy (MSA), a progressive disorder that is associated with selective degenerative cell loss in basal ganglia, cerebellum, brainstem, and spinal cord. The role of abnormal alpha-synuclein aggregation in oligodendroglial cells is still obscure, in particular, whether alpha-synuclein might impair oligodendroglial and, secondarily, neuronal integrity of those cells in the diseased brain. In an attempt to answer some of these questions, we have developed an "in vitro model of MSA" by expressing the wild-type or C-terminally truncated form of alpha-synuclein in glial cell cultures. With this simplified system, we have demonstrated that alpha-synuclein significantly affects the survival of glia and its vulnerability to environmental stress, which might represent a major step in the pathogenesis of MSA. Copyright 2005 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16092091     DOI: 10.1002/mds.20540

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

1.  α-Synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis.

Authors:  Zhengxin Ying; Fankai Lin; Weihong Gu; Yang Su; Abida Arshad; Hong Qing; Yulin Deng
Journal:  J Neural Transm (Vienna)       Date:  2011-02-20       Impact factor: 3.575

Review 2.  Multiple system atrophy: experimental models and reality.

Authors:  Cassia Overk; Edward Rockenstein; Elvira Valera; Nadia Stefanova; Gregor Wenning; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2017-10-20       Impact factor: 17.088

Review 3.  Animal modeling an oligodendrogliopathy--multiple system atrophy.

Authors:  Jonathan M Bleasel; Glenda M Halliday; Woojin Scott Kim
Journal:  Acta Neuropathol Commun       Date:  2016-02-09       Impact factor: 7.801

Review 4.  In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells.

Authors:  Elena Abati; Alessio Di Fonzo; Stefania Corti
Journal:  J Cell Mol Med       Date:  2018-03-04       Impact factor: 5.310

Review 5.  Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges.

Authors:  Alain Ndayisaba; Marcos Herrera-Vaquero; Gregor K Wenning; Nadia Stefanova
Journal:  Clin Auton Res       Date:  2019-06-11       Impact factor: 4.435

Review 6.  Models of multiple system atrophy.

Authors:  Diadem Ricarte; Darlene Ortiz; He-Jin Lee; Seung-Jae Lee
Journal:  Exp Mol Med       Date:  2019-11-18       Impact factor: 8.718

7.  Signs of early cellular dysfunction in multiple system atrophy.

Authors:  M Herrera-Vaquero; A Heras-Garvin; F Krismer; R Deleanu; S Boesch; G K Wenning; N Stefanova
Journal:  Neuropathol Appl Neurobiol       Date:  2020-09-17       Impact factor: 8.090

Review 8.  Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy.

Authors:  Nicole Campese; Alessandra Fanciulli; Nadia Stefanova; Johannes Haybaeck; Stefan Kiechl; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2021-07-28       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.